Publications

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells.

Wilhelmsen K, Khakpour S, Tran A, Sheehan K, Schumacher M, Xu F, Hellman J
From the journal archives: cyclopropane: induction and recovery with a bang!

Bokoch MP, Gelb AW
Quantitative in vitro assay to measure neutrophil adhesion to activated primary human microvascular endothelial cells under static conditions.

Wilhelmsen K, Farrar K, Hellman J
The dynamic process of β(2)-adrenergic receptor activation.

Nygaard R, Zou Y, Dror RO, Mildorf TJ, Arlow DH, Manglik A, Pan AC, Liu CW, Fung JJ, Bokoch MP, Thian FS, Kobilka TS, Shaw DE, Mueller L, Prosser RS, Kobilka BK
Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice.

Prakash A, Mesa KR, Wilhelmsen K, Xu F, Dodd-o JM, Hellman J
Lysine methylation strategies for characterizing protein conformations by NMR.

Larda ST, Bokoch MP, Evanics F, Prosser RS
Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation.

Lin T, Sammy F, Yang H, Thundivalappil S, Hellman J, Tracey KJ, Warren HS
ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes.

Wilhelmsen K, Mesa KR, Lucero J, Xu F, Hellman J
Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response.

Wilhelmsen K, Mesa KR, Prakash A, Xu F, Hellman J
Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Shin HS, Xu F, Bagchi A, Herrup E, Prakash A, Valentine C, Kulkarni H, Wilhelmsen K, Warren S, Hellman J